Medical Care in China

Nasopharyngeal carcinoma
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Precision ENT diagnosis and treatmentcovers diseases of the nose, ears, throat and head and neck.
Comprehensive ophthalmological treatmentcovers cataracts, glaucoma, and retinal diseases, etc.
Comprehensive oral restorationcovers implants, prosthodontics, and maxillofacial diseases.
Functional reconstruction supportsthe recovery of hearing, vision, and chewing functions.

Condition Guide

About Nasopharyngeal carcinoma

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Nasopharyngeal carcinoma is a malignant tumor that occurs in the nasopharyngeal mucosa. Its development is closely related to Epstein-Barr virus (EBV) infection, genetic susceptibility, and environmental factors (such as pickled foods and smoking) . Common symptoms include bloody nasal discharge, nasal congestion, tinnitus, ear fullness, hearing loss, and painless cervical lymphadenopathy. In advanced stages, headaches and double vision may occur. Nasopharyngeal carcinoma is a curable tumor. Early-stage patients can achieve good results with simple radical radiotherapy, with a 5-year survival rate exceeding 95%. Standardized initial diagnosis and treatment, along with comprehensive therapy, are key to improving the cure rate and reducing recurrence and metastasis.


Cutting-edge high-precision diagnostic and treatment technologies

 

  1. PD-1 Immunotherapy Combined with Radiotherapy and Chemotherapy : In addition to standard concurrent chemoradiotherapy, the combination of PD-1 inhibitors with high-risk locally advanced nasopharyngeal carcinoma can significantly improve event-free survival and reduce the risk of distant metastasis. It has become the new standard for high-risk patients with locally advanced disease. Multiple phase III clinical studies have confirmed its benefits. During treatment, it is necessary to routinely monitor adverse reactions such as immune-related pneumonia and hypothyroidism.
  2. Cisplatin-free chemotherapy regimen : This regimen optimizes chemotherapy administration and reduces concurrent cisplatin dosage while preserving the efficacy of immunotherapy and radiotherapy. This significantly reduces acute adverse reactions such as severe vomiting and bone marrow suppression, achieving efficacy comparable to the standard regimen. It balances efficacy and quality of life and is particularly suitable for older patients, those with poor tolerance, or those with severe previous chemotherapy reactions.
  3. EGFR×HER3 Bispecific Antibody-ADC : A domestically produced Class 1 innovative bispecific antibody-drug conjugate that can simultaneously target EGFR and HER3, precisely releasing cytotoxic drugs into tumor cells via a linker. It also exhibits bystander killing effect and is less prone to drug resistance. It is used for recurrent and metastatic nasopharyngeal carcinoma that has failed second-line chemotherapy and PD-1/PD-L1 inhibitor therapy, providing a new option for second-line treatment for refractory patients.
  4. GP chemotherapy combined with radiotherapy and immunotherapy : Gemcitabine combined with cisplatin systemic chemotherapy can eliminate distant micrometastases and reshape the body's anti-tumor immunity. Combined with local intensity-modulated radiotherapy and PD-1 monoclonal antibody, it achieves systemic and local synergy, significantly improving the efficacy of advanced and recurrent nasopharyngeal carcinoma. It is an important strategy for comprehensive treatment at present.

Care Overview

Nasopharyngeal carcinoma Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Liu Yunsong

Professor and Vice Dean, specializing in prosthodontics and digital diagnosis and treatment

ENT

Research areas: Clinical, teaching and research in prosthodontics, digital restoration, and implant restoration. Cutting-edge technology: Has long been engaged in clinical, teaching, and research work in prosthodontics. Has led 15 national and provincial-level research projects as principal investigator, published over 0 papers as first/corresponding author, including 2 ESI highly cited papers, and was consecutively listed among the top 2% of scientists globally in 2023 and 2024. Has obtained over 30 nati

National Center for Stomatology, Peking University School of Stomatology logo Affiliated Hospital National Center for Stomatology, Peking University School of Stomatology
Xu Gezhi

Chief Physician, Professor, Doctoral Supervisor, Former Director of Ophthalmology

ENT

-Research areas : vitreoretinal diseases, complex fundus surgery, severe ocular trauma; - Areas of expertise: 3D-navigated complex vitreoretinal surgery, repair of macular holes/recurrent retinal detachment; - Areas of expertise: Complex retinal detachment, proliferative diabetic retinopathy, high myopia macular degeneration, severe ocular rupture injury; - Academic Highlights & Core Values: Top domestic fundus surgeon, has completed numerous failed recurrent retinal detachment surgeries at other hospital

Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai ENT Hospital) logo Affiliated Hospital Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai ENT Hospital)
Zhuo Yehong

Professor, Chief Physician, Doctoral Supervisor, and Leader of Glaucoma Department

ENT

-Research areas : Glaucoma optic nerve protection, hereditary glaucoma, and surgery for refractory glaucoma. - Cutting-edge technology: Glaucoma drainage valve/drainage pin implantation, comprehensive optic nerve protection program for advanced glaucoma. - Areas of expertise: Primary angle-closure/open-angle glaucoma, refractory glaucoma with multiple postoperative relapses, and congenital glaucoma. - Academic Highlights: Led the compilation of the Chinese expert consensus on glaucoma diagnosis and treatm

Zhongshan Ophthalmic Center, Sun Yat-sen University logo Affiliated Hospital Zhongshan Ophthalmic Center, Sun Yat-sen University
Yi Hongliang

Chief Physician, Doctoral Supervisor

ENT

Research areas : obstructive sleep apnea, pharyngeal and head and neck tumors; Cutting-edge technology: Bimaxillary advancement (MMA) surgery for severe OSA; Areas of expertise: Severe snoring, pharyngeal tumors, pediatric snoring; Academic highlights: Leading expert in snoring surgery in China; Core value: Promoting precise OSA obstruction plane assessment to improve the surgical efficacy of severe snoring. Zhang Zhichang Associate Chief Physician, Doctoral Supervisor Research areas : Sacral and deep pel

Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital logo Affiliated Hospital Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital
Liu Yizhi

Representative of the discipline's founders, Level 2 Professor, Chief Physician, Doctoral Supervisor

ENT

-Research areas : ocular stem cells and lens regeneration; pathogenesis and treatment of cataracts. - Cutting-edge technology: Twisting-mode phacoemulsification cataract surgery, bimanual micro-incision phacoemulsification. Human lens regeneration (a major global medical breakthrough in 201). - Areas of expertise: Congenital cataracts, traumatic cataracts, complex cataracts complicated with glaucoma/uveitis, and lens diseases. - Academic Highlights: Executive Director of the Asia-Pacific Academy of Ophtha

Zhongshan Ophthalmic Center, Sun Yat-sen University logo Affiliated Hospital Zhongshan Ophthalmic Center, Sun Yat-sen University
Feng Guodong

Chief Physician, Professor, Doctoral Supervisor, Deputy Director of Department, Leading Person in Otolaryngology

ENT

-Research areas : Middle ear diseases, lateral skull base diseases, comprehensive diagnosis and treatment of tinnitus; - Areas of expertise: Cochlear implantation, ossicular chain reconstruction, and lateral skull base surgery; - Areas of expertise: Chronic otitis media, cholesteatoma, lateral skull base tumors, refractory tinnitus; - Academic Highlights & Core Values: Experts in promoting ear microsurgery techniques, focusing on multimodal comprehensive assessment of tinnitus and establishing individuali

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Patient Stories

See the Next Step Through Patient Journeys

Skeletal Class III Malocclusion - Reshaping Your Smile and Restarting a Confident Life CASE 01
PATIENT JOURNEY

Skeletal Class III Malocclusion - Reshaping Your Smile and Restarting a Confident Life

ENTCosmetic Surgery

Patient records Name: Nguyen Thi Lan Age: 22 years old Nationality: Vietnamese Diagnosis: Skeletal Class III malocclusion (underbite) Treatment Hospital: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Shanghai) Lan, a 22-year-old university student from Hanoi, Vietnam, is about to graduate. Despite her excellent grades, she suffers from severe underbite, which prevents her from smiling confidently and even affects her chewing and pronunciation. She dreams

View case details →
Cholesteatoma Otitis Media - Navigating the Fog and Regaining a New Voice Patient records CASE 02
PATIENT JOURNEY

Cholesteatoma Otitis Media - Navigating the Fog and Regaining a New Voice Patient records

ENT

Patient records Name: Budi Santoso Age: 45 Nationality: Indonesia Diagnosis: Cholesteatoma-type otitis media (involving the ossicular chain) Treatment Hospital: Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai) Budi, a 45-year-old high school music teacher from Jakarta, Indonesia, had been suffering from recurring ear discharge and hearing loss for nearly a year. Worse still, he began to lose his ability to distinguish pitch, a devastating blow to his career. Local doctors diagn

View case details →
Rhegmatogenous retinal detachment (macular involvement) - Redrawing light on a micrometer scale CASE 03
PATIENT JOURNEY

Rhegmatogenous retinal detachment (macular involvement) - Redrawing light on a micrometer scale

ENT

Patient records Name: Arif bin Ismail Age: 58 Nationality: Malaysia Diagnosis: Rhegmatogenous retinal detachment (macular involvement) Treatment Hospital: Zhongshan Ophthalmic Center, Sun Yat-sen University (Guangzhou) Arif, 58, from Kuala Lumpur, Malaysia, is a watch repairer. His world consists of intricate gears and delicate hairsprings, requiring exceptional vision. However, a week ago, a fixed black shadow suddenly appeared in his right eye's field of vision, like a giant curtain obscuring half the s

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.